Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026
Moderna (NASDAQ:MRNA) will report fourth quarter 2025 financial results on Friday, February 13, 2026 with a live conference call and webcast at 8:00 a.m. ET.
Rhea-AI Summary
Moderna (NASDAQ:MRNA) will report fourth quarter 2025 financial results on Friday, February 13, 2026 with a live conference call and webcast at 8:00 a.m. ET. The company will also provide a corporate update during the call.
A live webcast will be available under Events and Presentations in the Investors section of Moderna's website. The archived webcast will be posted about two hours after the call and will remain available for one year.
Details
News Market Reaction – MRNA
On Jan 26, the day this news came out, MRNA closed 1.48% below the previous close.
Data tracked by StockTitan Argus for the Jan 26 session.
Key Figures
- Earnings call time
- 8:00 a.m. ET
- Scheduled start time for fourth quarter 2025 call
- Earnings date
- February 13, 2026
- Date for fourth quarter 2025 financial results
- Results period
- Fourth quarter 2025
- Financial period to be reported on call
- Archive delay
- Two hours
- Time after call until archived webcast available
- Archive duration
- One year
- Length of time webcast replay will be available
Historical Context
-
Five-year Phase 2b melanoma data showing 49% reduction in recurrence or death.
-
J.P. Morgan presentation with 2025 revenue outlook, expense guidance, and cash levels.
-
Global filings for mRNA-1010 seasonal flu vaccine based on positive Phase 3 data.
-
CEPI commits up to $54.3M for Phase 3 H5 pandemic influenza vaccine trial.
-
Announcement of presentation slot at J.P. Morgan Healthcare Conference.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, MA / ACCESS Newswire / January 26, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 13, 2026 to report its fourth quarter 2025 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: https://investors.modernatx.com
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.